Jukić, A., Božić, D., Kardum, D., Bečić, T., Lukšić, B., Vrsalović, M. ... Fabijanić, D. (2017). Helicobacter pylori infection and severity of coronary atherosclerosis in patients with chronic coronary artery disease. Therapeutics and Clinical Risk Management, 13., 933-938. doi: 10.2147/TCRM.S142193
Jukić, Anita, et al. "Helicobacter pylori infection and severity of coronary atherosclerosis in patients with chronic coronary artery disease." Therapeutics and Clinical Risk Management, vol. 13, 2017, pp. 933-938. https://doi.org/10.2147/TCRM.S142193
Jukić, Anita, Dorotea Božić, Duško Kardum, Tina Bečić, Bruno Lukšić, Mislav Vrsalović, Marko Ljubković and Damir Fabijanić. "Helicobacter pylori infection and severity of coronary atherosclerosis in patients with chronic coronary artery disease." Therapeutics and Clinical Risk Management 13 (2017): 933-938. https://doi.org/10.2147/TCRM.S142193
Jukić, A., et al. (2017) 'Helicobacter pylori infection and severity of coronary atherosclerosis in patients with chronic coronary artery disease', Therapeutics and Clinical Risk Management, 13, pp. 933-938. doi: 10.2147/TCRM.S142193
Jukić A, Božić D, Kardum D, Bečić T, Lukšić B, Vrsalović M, and sur.. Helicobacter pylori infection and severity of coronary atherosclerosis in patients with chronic coronary artery disease. Therapeutics and Clinical Risk Management [Internet]. 2017 July 27 [cited 2024 November 10];13:933-938. doi: 10.2147/TCRM.S142193
A. Jukić, et al., "Helicobacter pylori infection and severity of coronary atherosclerosis in patients with chronic coronary artery disease", Therapeutics and Clinical Risk Management, vol. 13, pp. 933-938, July 2017. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:866181. [Accessed: 10 November 2024]